Mr. Garland's expertise in biopharma is predicted to boost l...
Mr. Garland's expertise in biopharma is predicted to boost late-stage development of Olema's lead product. This could solidify the company's influence in shaping next-gen therapies for women's cancers.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000232b0075cec7b6.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment